Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1510503
European Journal of Endocrinology, Vol 151, Issue 4, 503-510
Copyright © 2004 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Modder, U.
Right arrow Articles by Khosla, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Modder, U.
Right arrow Articles by Khosla, S

Articles

Dose-response of estrogen on bone versus the uterus in ovariectomized mice

UI Modder, BL Riggs, TC Spelsberg, DG Fraser, EJ Atkinson, R Arnold, and S Khosla

Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

BACKGROUND: Estrogen is known to have important effects on both reproductive and non-reproductive tissues. Moreover, there is increasing interest in developing compounds that may have selective effects on bone versus reproductive tissues. METHODS: Since mouse models are often used in these studies, we administrated increasing doses of estradiol (E2) (0 to 500 microg/kg/day) by slow release pellets to ovariectomized 6-month-old C57BL/6 mice and assessed skeletal and uterine responses following 2 months of treatment. RESULTS: The mice lost bone at multiple sites following ovariectomy (OVX); however, while the lowest E2 dose of 5 microg/kg/day completely prevented loss of cancellous bone (at the lumbar spine and tibial metaphysis), it had no stimulatory effects on the uterus. Higher doses of E2 resulted in further increases in bone mineral density, with eventual stimulation of the uterus at a dose of 40 microg/kg/day. By contrast, when 3-month-old C57BL/6 mice were administered the same doses of E2 and studied after 1 month, the 5 microg/kg/day dose resulted in uterine hypertropy, but was not able to prevent loss of cancellous bone. CONCLUSIONS: Thus these results (i) provide data on the dose-response for the effects of E2 on mouse bone and (ii) indicate that the relative effects of E2 on bone versus the uterus are highly dependent on the particular experimental conditions used. This issue needs to be considered in evaluating agents with potential 'selective' effects on bone versus reproductive tissues.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. E. Govoni, J. E. Wergedal, R. B. Chadwick, A. K. Srivastava, and S. Mohan
Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1172 - E1180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Game, J. Allard, G. Escourrou, P. Gourdy, I. Tack, P. Rischmann, J.-F. Arnal, and B. Malavaud
Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R851 - R857.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N. Andersson, U. Islander, E. Egecioglu, E. Lof, C. Swanson, S. Moverare-Skrtic, K. Sjogren, M. K Lindberg, H. Carlsten, and C. Ohlsson
Investigation of central versus peripheral effects of estradiol in ovariectomized mice
J. Endocrinol., November 1, 2005; 187(2): 303 - 309.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. Fintini, M. Alba, and R. Salvatori
Influence of Estrogen Administration on the Growth Response to Growth Hormone (GH) in GH-Deficient Mice
Experimental Biology and Medicine, November 1, 2005; 230(10): 715 - 720.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 European Society of Endocrinology.